Clinical Trial Update: Gene Therapy for the Treatment of Chronic Stable Angina [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 gene therapy trial for chronic stable angina (myocardial ischemia) sponsored by Helixmith was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia
• Stable Angina

Drugs mentioned

• Investigational gene therapy for chronic stable angina (NCT01002495)

Snippet

Sponsor: Helixmith Co., Ltd. | Conditions: Myocardial Ischemia | Phase 1, Phase 2 | Status: WITHDRAWN